Two news which hit the wire at about the same time
The substance in the first study looks like it may (without trying we will never know for sure; hence I just say "may") be the most potent recomp drug ever, building muscle and shedding fat.
Check out the profile of this in Wikipedia:
"In January 2021, a new study confirmed that treatment with Bimagrumab is safe and effective for treating excess adiposity and metabolic disturbances of adult patients with obesity and type 2 diabetes"
So its not like we are talking about an untested substance. It has been substantially tested.
The other is a much more experimental substance and is called FST-DHBS-mFc.
Any chance the first one can be synthesized (I know, I know... synthesize is not the right term here; this is a monoclonal antibody) ???
Bimagrumab | A muscle enhancer turns into a fat loss drug
Pharmaceutical company Novartis is conducting trials with the myostatin blocker bimagrumab, we wrote in 2017. Trials in which people with the rare muscle disease sporadic inclusion body myositis received bimagrumab have failed, but a recent trial sugests that the new drug may more more...
www.ergo-log.com
New follistatin analogue makes muscles 19 percent larger in a week
Danish researchers have developed a drug that deactivates the muscle growth inhibiting protein myostatin, but does not have the side effect that hangs like a dark shadow over current myostatin research. When the Danes gave test animals a modified verrsion of follistatin for a week, their muscle...
www.ergo-log.com
The substance in the first study looks like it may (without trying we will never know for sure; hence I just say "may") be the most potent recomp drug ever, building muscle and shedding fat.
Check out the profile of this in Wikipedia:
Bimagrumab - Wikipedia
en.wikipedia.org
So its not like we are talking about an untested substance. It has been substantially tested.
The other is a much more experimental substance and is called FST-DHBS-mFc.
Any chance the first one can be synthesized (I know, I know... synthesize is not the right term here; this is a monoclonal antibody) ???